According to a new report, published by KBV research, The Global Novel Spectrometry Market size is expected to reach $14.17 billion by 2031, rising at a market growth of 19.7% CAGR during the forecast period.
The Analytical Testing & Diagnostics segment is anticipating a CAGR of 18.8% during (2025 - 2032). This dominance is primarily due to the increasing demand for precise and rapid diagnostic tools in the healthcare and pharmaceutical sectors. Clinical laboratories use Novel spectrometry techniques to detect biomarkers, monitor metabolic profiles, and identify disease-related compounds. The growing focus on personalized medicine and early disease detection has further accelerated the adoption of advanced spectrometry tools in diagnostic applications.
The Mass Spectrometry (MS) segment is leading the Global Novel Spectrometry Market by Type in 2024; thereby, achieving a market value of $4.16 billion by 2032. Its robust application in drug discovery, proteomics, metabolomics, and forensic science drives this. Mass spectrometry offers high accuracy, sensitivity, and the ability to identify complex mixtures and unknown compounds, making it an essential tool in modern analytical laboratories. Advancements in hybrid technologies such as tandem mass spectrometry (MS/MS) and time-of-flight (TOF) systems have significantly contributed to the growth of this segment.
The agriculture segment is registering a CAGR of 19% during (2025 - 2032). Spectrometry technologies are increasingly utilized in agriculture for soil analysis, crop health monitoring, pesticide residue detection, and nutrient profiling. These tools support precision farming practices, enabling farmers to make data-driven decisions that enhance yield and sustainability. The rising global demand for food security and sustainable agricultural practices has significantly contributed to adopting novel spectrometry solutions within this segment.
Full Report: https://www.kbvresearch.com/novel-spectrometry-market/
The North America region dominated the Global Novel Spectrometry Market by Region in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $5.3 billion by 2032. The Europe region is experiencing a CAGR of 19.5% during (2025 - 2032). Additionally, The Asia Pacific region would exhibit a CAGR of 20.4% during (2025 - 2032).
By Application
By Type
By End Use
By Geography
Unique Offerings 
